TrialArthritis research & therapy2019

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).

Zixuan Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.